優億榮獲2024傑出生技產業獎──傑出新創獎
TAIPEI, Taiwan Jul. 10, 2024 – ImmunAdd won the Startup of the Year at the 2024 Taiwan BIO Awards and the Awards ceremony will be held on July 25th. ImmunAdd is a biotech pharmaceutical research and development company focused on drug design and formulation development. ImmunAdd was founded in 2022 but has put efforts into researching synthetic saponin for nearly a decade.
ImmunAdd’s first product, IA-05, is designed as a vaccine adjuvant, which could be incorporated into a vaccine product to improve efficacy and extend the protection period. IA-05 exhibits comparable adjuvant activity to QS-21 and is safer when used in combination with various vaccines.
“The development of IA-05 and its proven effect marks a major milestone in the field of vaccine adjuvants” Dr. Pi-Hui Liang, CEO said. “We have developed a total synthesis method for saponin adjuvants that not only meets the growing demand but also protects the forest and ensures the long-term sustainable supply of the adjuvant.”
ImmunAdd is now seeking partnerships to co-develop innovative and practical pharmaceutics for better health.
“Innovation for better health”
We are ImmunAdd.
#2024 BIO Asia-Taiwan 活動記者會
#2024 BIO Asia-Taiwan “Taiwan BIO Awards-Successful Stories”發表會
#2024 BIO Asia-Taiwan “Taiwan BIO Awards” 頒獎典禮